Janssen covid-19 vaccine

''The Johnson & Johnson covid-19 vaccine is a covid-19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands, and its Belgian parent company Janssen Pharmaceuticals, subsidiary of American company Johnson & Johnson. It is a viral vector vaccine based on a human adenovirus that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID-19. The body's immune system responds to this spike protein to produce antibodies. The vaccine requires only one dose and does not need to be stored frozen''.

News

 * 14 Apr 2021, (fr) 7sur7.be, Johnson & Johnson demande à ne pas administrer le vaccin dans l’attente de la décision de l'EMA
 * 13 Apr 2021, Politico.eu, J&J vaccine suspension in US raises fears it’s the next AstraZeneca, So far, no EU countries said they would not use the vaccine — even if the company itself said it would pause the rollout.
 * 13 Apr 2021, Politico.eu, J&J delays European vaccine rollout over blood clotting concerns in US, The EU was set to start using the vaccine this week.
 * 13 Apr 2021, FDA.gov, Joint CDC and FDA Statement on Johnson & Johnson covid-19 vaccine, As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine.
 * 12 Apr 2021, Reuters.com, J&J begins covid-19 vaccine supplies to EU, 50 million doses expected in second quarter: lawmaker
 * 10 Apr 2021, TheEconomist.com, With millions vaccinated, rare side-effects of jabs are emerging, Johnson & Johnson’s vaccine is the latest to suffer a setback. The six blood clot cases investigated by American officials for the Johnson & Johnson jab were also accompanied by low platelet counts. They were all in women under 50, but that could be in large part because the jab has been widely used for essential workers who are predominantly women.
 * 29 Mar 2021, (fr) 7sur7.be, Janssen fournira jusqu'à 400 millions de doses de vaccin aux 55 pays membres de l'Union africaine, "Johnson & Johnson part du principe que personne n'est en sécurité tant que tout le monde n'est pas en sécurité. Nous nous engageons à un accès mondial équilibré aux nouveaux vaccins Covid-19", a déclaré Alex Gorsky, PDG de Johnson & Johnson.
 * 15 Mar 2021, Politico.eu, Johnson & Johnson picks German site for coronavirus vaccine production, The producer will use a site usually used for a dengue fever jab.
 * 12 Mar 2021, Politico.eu, WHO gives green light to J&J vaccine, This is the third vaccine to receive emergency use listing from the WHO, following Oxford/AstraZeneca and Pfizer/BioNTech.
 * 11 Mar 2021, Politico.eu, EU regulator recommends J&J coronavirus vaccine for use, The company will not start delivering doses to Europe until April.
 * 11 Mar 2021, (fr) LeSoir.be, Coronavirus: l’Agence européenne des médicaments donne son feu vert au vaccin de Johnson & Johnson, Le vaccin contre le coronavirus de Johnson & Johnson a reçu ce jeudi son autorisation de mise sur le marché UE
 * 10 Mar 2021, Politico.eu, Despite expected approval, J&J vaccine won’t fix EU’s supply crunch, The EU will approve its fourth vaccine Thursday, but it will take at least another three weeks to get doses.